Filter Results:
(1,462)
Show Results For
- All HBS Web
(1,462)
- People (7)
- News (353)
- Research (921)
- Multimedia (2)
- Faculty Publications (433)
Show Results For
- All HBS Web
(1,462)
- People (7)
- News (353)
- Research (921)
- Multimedia (2)
- Faculty Publications (433)
- 20 Feb 2007
- First Look
First Look: February 20, 2007
Co.: Breaking New Grounds Harvard Business School Case 807-004 Examines the strategies of a Boston-based start-up to market Rwandan coffee. Describes the history of the coffee... View Details
Keywords: Martha Lagace
- Web
Connect with Clubs - Recruiting
grcc@studentclubs.hbs.edu Health & Wellness Club Co-Presidents Brooke Robinson brobinson@mba2026.hbs.edu Maggie Richardson mrichardson@mba2026.hbs.edu Health Care Club... View Details
- 15 Oct 2013
- First Look
First Look: October 15
Returns By: Greenwood, Robin, and Dimitri Vayanos Abstract—We examine empirically how the maturity structure of government debt affects bond yields and excess returns. Our analysis is based on a theoretical... View Details
Keywords: Sean Silverthorne
- 07 Feb 2012
- First Look
First Look: February 7
fairness within the industry. Coordinating conflicting programs requires a careful balance between equity and efficiency. In our work, we first develop a fairness metric to measure deviation from first-scheduled, first-served in the... View Details
Keywords: Sean Silverthorne
- August 2009 (Revised April 2012)
- Case
Genzyme's CSR Dilemma: How to Play its HAND
By: Christopher A. Bartlett, Tarun Khanna and Prithwiraj Choudhury
Genzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases (e.g., malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should... View Details
Keywords: Global Strategy; Health Care and Treatment; Intellectual Property; Corporate Social Responsibility and Impact; Partners and Partnerships; Research and Development; Biotechnology Industry
Bartlett, Christopher A., Tarun Khanna, and Prithwiraj Choudhury. "Genzyme's CSR Dilemma: How to Play its HAND." Harvard Business School Case 910-407, August 2009. (Revised April 2012.)
- Web
Topics - HBS Working Knowledge
Financial Markets (22) Financial Reporting (7) Financial Statements (1) Financial Strategy (11) Financing and Loans (22) Food (12) For-Profit Firms (1) Forecasting and Prediction (26) Foreign Direct Investment (5) Forms View Details
- 19 Jul 2011
- First Look
First Look: July 19
related activities). We consider whether there are similar benefits to related diversification within an operating unit and examine the mechanism that generates these benefits. Using the empirical context of cardiovascular View Details
Keywords: Sean Silverthorne
- Web
2023 Reunion Presentations - Alumni
relaxing the ownership role of physicians in such sites. Some health insurers added technology as a major asset, and VCs and PEs invested heavily in these innovative businesses. Many View Details
- February 2021 (Revised May 2021)
- Case
SafeGraph: Selling Data as a Service
By: Ramana Nanda, Abhishek Nagaraj and Allison Ciechanover
Set in January 2021, the CEO of SafeGraph, a four-year-old startup that sold Data as a Service, looked to the future. His aim was to become the most trusted source for data about a physical place. The company provided points of interest (POI) and foot traffic data on... View Details
Keywords: Data As A Service; Monetization; Pricing; Business Startups; Analytics and Data Science; Consumer Behavior; Analysis; Business Model; Health Pandemics; Information Industry; United States
Nanda, Ramana, Abhishek Nagaraj, and Allison Ciechanover. "SafeGraph: Selling Data as a Service." Harvard Business School Case 821-082, February 2021. (Revised May 2021.)
- 21 Aug 2000
- Research & Ideas
Inside the OR: Disrupted Routines and New Technologies
an order giver to a team member in an interdependent process." Making A Team Successful In The Face Of Disrupted Routines Through the analysis of detailed qualitative and... View Details
Keywords: by Hilah Geer
- 13 Jul 2023
- News
The Network Effect
whose background was in investment banking and health care consulting, wanted to become a health care investor. Both were attracted to the View Details
- June 2003 (Revised May 2006)
- Case
Cipla
By: Rohit Deshpande and Laura Winig
The head of Cipla, a $325-million-dollar Indian pharmaceutical company and seller of low-cost AIDS drugs to South Africa, must decide what to do about Cipla's future. With India poised to enforce international patents in only two years, much of Cipla's product line... View Details
- Web
Publications - Institute For Strategy And Competitiveness
Tests for Physicians and Their Leaders for the Decade Ahead by Thomas H. Lee, MD, MSc, Toby Cosgrove, MD In the years immediately ahead, physicians and their leaders must move to a new level of health View Details
- 01 Dec 2023
- News
Thinking Ahead
business of delivering health care than making a diagnosis and prescribing medication,” she says. Today, as cofounder and CEO of Systole, a... View Details
- 01 Nov 2016
- First Look
First Look - November 1, 2016
America Innovation Network By: Acemoglu, Daron, Ufuk Akcigit, and William R. Kerr Abstract— Technological progress builds upon itself, with the expansion of invention in one domain propelling future work in linked fields. Our View Details
Keywords: Sean Silverthorne
- 12 Mar 2019
- First Look
New Research and Ideas, March 12, 2019
available. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=55802 forthcoming Journal of Medical Economics Time-Driven Activity-Based Cost Analysis for Outpatient Anticoagulation Therapy:... View Details
Keywords: Dina Gerdeman
- January 2021 (Revised June 2021)
- Case
Hester Pharmaceuticals (A): A Pricing Dilemma
By: Dante Roscini and John Masko
In August 2019, the leadership of Hester Pharmaceuticals (Hester) had a problem. Italy promised to be a key market for their new breakthrough oncology drug Akrozumab, but for almost two years, its single-payer healthcare system had been unable to agree with Hester on a... View Details
Keywords: Macroeconomics; Trade; Price; Global Range; Global Strategy; Globalized Markets and Industries; Health Care and Treatment; Patents; Monopoly; Negotiation; Business and Government Relations; Risk and Uncertainty; Human Needs; Business Strategy; Commercialization; Pharmaceutical Industry; Italy
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (A): A Pricing Dilemma." Harvard Business School Case 721-001, January 2021. (Revised June 2021.)
- 05 Jun 2007
- First Look
First Look: June 5, 2007
Case 707-559 Describes the joint efforts of the German health plan KKH and Essen University Hospital to develop an integrated practice unit (IPU), and the West German Headache Center's efforts to improve the... View Details
Keywords: Martha Lagace
- Web
Entrepreneurship - Recruiting
Salary $160,000 Industries Consumer Products 3% Entertainment / Media 3% Financial Services 7% Health Care 17% Manufacturing 8% Nonprofit / Government 2% Retail 2% Services 3% Technology 55% Functions... View Details